https://jadpro.com/best-practices-summit/
JADPRO | Best Practices Summit
best practicesjadprosummit
https://jadprolive.com/
JADPRO Live
An Educational Event for Advanced Practitioners in Oncology
jadprolive
https://jadpro.com/issues/volume-4-number-3-mayjun-2013/energy-therapies-in-advanced-practice-oncology-an-evidence-informed-practice-approach/
JADPRO | Energy Therapies in Advanced Practice Oncology: An Evidence-Informed Practice Approach
Discover the use of Therapeutic Touch, Healing Touch, and Reiki in oncology settings, and explore their impact on cancer care and patient well-being.
energy therapiesadvanced practicejadpro
https://jadpro.com/issues/volume-5-number-5-sepoct-2014/ibrutinib-in-relapsed-or-refractory-mantle-cell-lymphoma-and-chronic-lymphocytic-leukemia/
JADPRO | Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
mantle cell lymphoma
https://jadpro.com/issues/volume-8-number-4-mayjun-2017/palliative-chemotherapy-does-it-only-provide-false-hope/
JADPRO | Palliative Chemotherapy: Does It Only Provide False Hope?
jadpropalliativechemotherapyprovidefalse
https://www.jadpro.com/cme-supplements/volume-9-supplement-1-novdec-2018/drug-drug-interactions-in-melanoma/
JADPRO | Drug-Drug Interactions in Melanoma
drug interactionsjadpromelanoma
https://jadprolive2025.eventscribe.net/index.asp
JADPRO Live 2025
jadpro live
https://www.jadpro.com/issues/volume-4-number-4-julaug-2013/optimizing-adherence-to-adjuvant-imatinib-in-gastrointestinal-stromal-tumor/
JADPRO | Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
Explore the latest insights on gastrointestinal stromal tumors and the challenges of prolonged therapy with imatinib.
jadprooptimizingadherenceadjuvantimatinib
https://www.jadpro.com/issues/volume-12-number-2-mar-2021/integration-of-palliative-care-in-the-role-of-the-oncology-advanced-practice-nurse/
JADPRO | Integration of Palliative Care in the Role of the Oncology Advanced Practice Nurse
palliative carein the
https://jadpro.com/user/login?returnUrl=https://jadpro.com/issues/volume-4-number-2-marapr-2013/polypharmacy-in-older-adults-the-role-of-the-advanced-practitioner-in-oncology/
JADPRO | Login
Log in to read full-text articles from the Journal of the Advanced Practitioner in Oncology (JADPRO).
jadpro
https://www.jadpro.com/issues/volume-5-number-1-janfeb-2014/the-long-and-short-of-tamoxifen-therapy-a-review-of-the-atlas-trial/
JADPRO | The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial
Explore the evolution and impact of tamoxifen therapy in breast cancer treatment on mortality rates and patient outcomes.
https://conversations.advancedpractitioner.com/peer-perspectives-with-natasha-l-johnson-and-kathryn-herricks/beyond-the-numbers-navigating-the-challenges-of-myelofibrosis-care/
JADPRO Peer Perspectives
JADPRO Peer Perspectives
jadpropeerperspectives
https://jadpro.com/issues/volume-8-number-1-janfeb-2017/jl427-the-effect-of-prophylactic-naproxen-prophylactic-loratadine-or-no-prophylaxis-on-bone-pain-in-patients-with-breast-cancer-receiving-chemotherapy-and-pegfilgrastim/
JADPRO | JL427. The Effect of Prophylactic Naproxen, Prophylactic Loratadine, or No Prophylaxis on...
the effect
https://www.jadpro.com/issues/volume-8-number-1-janfeb-2017/jl415-nurses-championing-exercise-in-survivorship-care-clinic-visits/
JADPRO | JL415. Nurses Championing Exercise in Survivorship Care Clinic Visits
survivorship carejadpronurseschampioningexercise
https://www.jadpro.com/issues/volume-12-number-5-july-2021/treatment-options-for-germline-brca-mutated-metastatic-pancreatic-adenocarcinoma/
JADPRO | Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
treatment optionsjadprogermlinebrcametastatic
https://www.jadpro.com/videos/meeting-highlights/2023-asco-annual-meeting/new-findings-on-cll-covid-19-and-treatment-with-obinutuzumab-plus-venetoclax/
JADPRO | New Findings on CLL, COVID-19, and Treatment With Obinutuzumab Plus Venetoclax
https://www.jadpro.com/issues/volume-8-number-6-sepoct-2017/venetoclax-a-novel-treatment-for-patients-with-del-17p-chronic-lymphocytic-leukemia/
JADPRO | Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
for patients with
https://www.jadpro.com/user/login/?returnUrl=https://www.jadpro.com/sections/grand-rounds/
JADPRO | Login
Log in to read full-text articles from the Journal of the Advanced Practitioner in Oncology (JADPRO).
jadpro
https://www.jadprolive.com/branding-and-sponsorship-opportunities/
JADPRO Live
An Educational Event for Advanced Practitioners in Oncology
jadprolive
https://www.jadpro.com/cme-supplements/volume-10-supplement-1-mar-2019/immuno-oncology-essentials-an-overview/
JADPRO | Immuno-Oncology Essentials: An Overview
immuno oncologyjadproessentialsoverview
https://www.jadpro.com/user/login?returnUrl=https://www.jadpro.com/issues/volume-3-number-6-novdec-2012/effects-of-aspirin-on-colorectal-cancer-related-to-lynch-syndrome/
JADPRO | Login
Log in to read full-text articles from the Journal of the Advanced Practitioner in Oncology (JADPRO).
jadpro
https://www.jadpro.com/cme-supplements/volume-8-supplement-1-julaug-2017/
JADPRO | Volume 8, Supplement 1 (Jul/Aug 2017)
Lung cancer is the leading cause of cancer-associated mortality and late diagnosis is a fundamental obstacle to improving outcomes in lung cancer, exacerbating...
jadprovolumesupplementjulaug
https://www.jadprolive.com/exhibitor-faq/
JADPRO Live
An Educational Event for Advanced Practitioners in Oncology
jadprolive
https://jadpro.com/user/login?returnUrl=https://jadpro.com/issues/volume-11-number-1-janfeb-2020/dihydropyrimidine-dehydrogenase-deficiency-to-screen-or-not-to-screen/
JADPRO | Login
Log in to read full-text articles from the Journal of the Advanced Practitioner in Oncology (JADPRO).
jadpro
https://www.jadpro.com/user/login/?returnUrl=https://www.jadpro.com/topics/solid-tumors/breast-cancer/
JADPRO | Login
Log in to read full-text articles from the Journal of the Advanced Practitioner in Oncology (JADPRO).
jadpro
https://www.jadpro.com/issues/volume-14-number-5-julaug-2023/quality-of-life-in-adult-cancer-patients-with-underage-children-an-integrative-review/
JADPRO | Quality of Life in Adult Cancer Patients With Underage Children: An Integrative Review
The article explores the challenges and impact of a cancer diagnosis on parents with children under 18, emphasizing the importance of assessing their quality...
https://conversations.advancedpractitioner.com/peer-perspectives-with-allison-strider-and-sarah-worth-on-chronic-myeloid-leukemia/cml-treatment-considerations-in-the-community-setting/
JADPRO Peer Perspectives
JADPRO Peer Perspectives
jadpropeerperspectives
https://jadpro.com/issues/volume-9-number-1-janfeb-2018/jl510-febrile-neutropenia-risk-assessment-prior-to-chemotherapy-and-use-of-colony-stimulating-factor-prophylaxis-in-us-community-oncology-clinics/
JADPRO | JL510. Febrile Neutropenia Risk Assessment Prior to Chemotherapy and Use of...
risk assessment
https://www.jadpro.com/issues/volume-13-number-7-sepoct-2022/development-of-a-standardized-bone-marrow-procedure-training-and-competency-toolkit-for-advanced-practice-providers-in-a-large-community-oncology-practice/
JADPRO | Development of a Standardized Bone Marrow Procedure Training and Competency Toolkit for...
https://www.jadpro.com/issues/volume-12-number-3-apr-2021/
JADPRO | Volume 12, Number 3 (Apr 2021)
jadprovolumenumberapr
https://conversations.advancedpractitioner.com/peer-perspectives-with-zita-lim-and-emily-lemke-on-renal-cell-carcinoma/best-practices-in-managing-side-effects-associated-with-renal-cell-carcinoma-treatment/
JADPRO Peer Perspectives
JADPRO Peer Perspectives
jadpropeerperspectives
https://www.jadpro.com/cme-supplements/volume-17-number-1-marapr-2026/new-frontiers-in-neuroendocrine-tumors-enhancing-diagnosis-treatment-and-patient-outcomes/
JADPRO | New Frontiers in Neuroendocrine Tumors Enhancing Diagnosis, Treatment, and Patient Outcomes
A session at JADPRO Live 2025 provided a comprehensive overview of neuroendocrine tumors (NETs), emphasizing how advances in diagnosis, imaging, systemic...
new frontiersneuroendocrine tumors
https://www.jadpro.com/issues/volume-8-number-2-mar-2017/managing-constipation-in-adults-with-cancer/
JADPRO | Managing Constipation in Adults With Cancer
jadpromanagingconstipationadultscancer
https://www.jadpro.com/issues/volume-6-number-6-novdec-2015/managing-patients-with-myelofibrosis-in-the-era-of-janus-kinase-inhibitors/
JADPRO | Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors
Explore the impactful role of ruxolitinib in managing myelofibrosis and the challenges faced by advanced practitioners in patient care.
managing patients
https://www.jadpro.com/issues/volume-12-number-3-apr-2021/developments-in-hepatocellular-cancer-treatment/
JADPRO | Developments in Hepatocellular Cancer Treatment
jadprodevelopmentshepatocellularcancertreatment
https://www.jadpro.com/issues/volume-14-number-2-mar-2023/teclistamab-cqyv-the-first-bispecific-t-cell-engager-antibody-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma/
JADPRO | Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of...
Discover the promising efficacy of teclistamab-cqyv, a bispecific T-cell engager therapy, in heavily pretreated multiple myeloma patients.
https://www.jadpro.com/videos/meeting-highlights/2019-ash-annual-meeting/medalist-trial-of-luspatercept-to-treat-anemia/
JADPRO | MEDALIST Trial of Luspatercept to Treat Anemia
jadpromedalisttrialtreatanemia
https://tigerlilyfoundation.org/event/the-annual-apsho-jadpro-live-virtual-2021/
The Annual APSHO JADPRO Live Virtual 2021 - Tigerlily Foundation
New Paths to Patient Care - Keynote Presentation by Maimah Karmo
the annualjadpro liveapshovirtualtigerlily
https://www.jadpro.com/videos/meeting-highlights/2020-ash-annual-meeting/converting-minimal-residual-disease-in-multiple-myeloma/
JADPRO | Converting Minimal Residual Disease in Multiple Myeloma
minimal residual diseasejadproconvertingmultiplemyeloma
https://www.jadpro.com/issues/volume-12-number-3-apr-2021/sticky-issues-what-aps-need-to-know-about-anticoagulants-and-patients-with-cancer/
JADPRO | Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer
https://www.jadpro.com/issues/volume-12-number-6-aug-2021/breast-cancer-2021-asco-annual-meeting-highlights-for-the-advanced-practitioner/
JADPRO | Breast Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
asco annual meetingbreast cancer